← Back to case list
Sichuan Yazhong Medical Instruments
Pharmaceutical and MedicalInput and Output Management
Sichuan Yazhong Medical Instruments · Medical device distribution enterprise

Sichuan Yazhong Medical Instruments | Input digital account invoice retrieval and verification

Digital account invoice retrievalCore Capabilities
Prevent missing invoicesManagement value

Enterprise overview

Sichuan Yazhong Medical Instrument Co., Ltd. was founded in 1999 and is headquartered in Chengdu. It is an in vitro diagnostics service platform integrating three major businesses: IVD overall solutions, cold-chain pharmaceutical logistics, and regional testing centers. It has branches in Chongqing, Kunming, and Guiyang, and with four major operations centers as its foundation, its business covers the entire Southwest and Northwest regions. The company provides systematic services from laboratory planning, design and decoration, equipment configuration and selection, installation and system maintenance to cold-chain transportation, and also carries out IVD laboratory entrusted management and third-party cold-chain warehousing and distribution services compliant with GSP requirements. It is a first-tier distributor for Roche Diagnostics, Cepheid, and Mindray in the Southwest region.

Business pain points

  • Daily procurement covers pharmaceuticals and consumables, testing reagents, medical equipment, logistics services, and professional outsourcing. Supplier qualification requirements are high, invoice compliance standards are strict, and expense attribution for different departments and projects needs to be accounted for separately. Invoice images are photographed and uploaded by the handler; shooting angle, lighting, and wrinkles all affect readability, and finance often has to re-verify against the original during review. Entry errors propagate along certification, deduction, and vouchers, making post-event correction costly
  • Duplicate reimbursement relies on memory and ledger comparison, and duplicates across periods and departments are hard to detect. Under spot-check methods, abnormal invoices are often exposed only at the certification stage, by which time the business has already completed payment
  • Voided invoices and red-flushed invoices mixed into accounts directly affect input VAT deduction and cost recognition. After China Golden Tax Phase IV, tax comparison tends toward full quantification. Once invoice authenticity has problems, it directly affects deduction, and spot-check verification can no longer cover regulatory requirements

Solutions

  • Introduce recognition capabilities covering all invoice types, automatically extract and structurally output invoice information, directly write it back to business systems, and eliminate manual entry one by one
  • Automatically connect to tax authority verification to check invoice number, amount, invoicing date and issuer status, and perform cross-period duplicate reimbursement comparison
  • Items with low recognition confidence are separately pushed for manual review, while the rest of the full process is unattended
  • Ultimately upgrades verification coverage from sampling to full volume, intercepting anomalies before booking, with verification records retained for future reference
  • And opening recognition and verification capabilities to other business systems for invocation, avoiding duplicate construction of similar capabilities across systems
Related solutions
Input invoice collection management platform
Full-process control of intelligent collection, check-and-authenticate, and risk interception →
Enterprise expense control and reimbursement system
Intelligent reimbursement, compliance control, one-click bookkeeping →
Tax Risk Control Platform
China Golden Tax Phase IV tax-related risk early warning, blocking audits before they occur →
Telephone consultationBook a Demo
Home AI digital employee Core products Customer Stories Insights Book a Demo
010-60974119